Neurobiological Tech (NTII) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Neurobiological Tech (NTII)

An SI Board Since September 1996

Posts	SubjectMarks	Bans	Symbol
1494	40	0	NTII

Emcee: Miles Rhyne Hoffman, CFA	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
19	Never mind, Mike, I see that you've filled in your user profile, and that y	scaram(o)uche	-	10/15/1996
18	First of all, you need to answer my earlier question. :-) The best, by far,	scaram(o)uche	-	10/15/1996
17	Boyce, you don't think Somatogen is a possibility for the long haul? I don&	Michael Collins	-	10/14/1996
16	Rick, I noticed that you are very negative on Sturza's newsletter. I just	Michael Collins	-	10/14/1996
15	The research of NTII got a rave review in the most recent issue of the Ed Welle	Dr. John M. de Castro	-	10/11/1996
14	Message from Boyce Burge on Oct 9 1996 2:29PM EST Biotech Newsletters in	scaram(o)uche	-	10/9/1996
13	Thanks for your response. I'll look more closely at NTII. I admit I haven	Boyce Burge	-	10/9/1996
12	I have mixed feelings about Tracy's recommendations. He also picked CORX.	scaram(o)uche	-	10/8/1996
11	I was worried about this myself. So. I looked into it before investing in	Dr. John M. de Castro	-	10/2/1996
10	There have been fears of Cerestat side effects mitigating against emergency roo	John Metcalf	-	10/1/1996
9	I have no particular opinion about NTII, but want to know more since I follow	Boyce Burge	-	10/1/1996
8	Thanks, Howard. The listserv is very quiet and well disguised. :-) Everything	scaram(o)uche	-	9/28/1996
7	It is good to see you on this forum. I certainly remember your posts--you made	Howard Frederick	-	9/27/1996
6	I'm one of those dated m.i.s opinions. :-) I first learned about memanti	scaram(o)uche	-	9/27/1996
5	The licensing agreements vary with the institution involved. With many of N	Dr. John M. de Castro	-	9/24/1996
4	NTII does have an interesting business model. Do you have any insight as to th	Howard Frederick	-	9/24/1996
3	I've been following NTII since March of this year and have posted on	Dr. John M. de Castro	-	9/20/1996
2	Howard---Ed Welles' COMMON STOCKS, COMMON SENSE picked up NTII in his July,	Dan Jones	-	9/20/1996
1	A recent (PR Newswire) news release about dynorphin A Phase II clinicals indica	Howard Frederick	-	9/20/1996

Go to reply# or date (mm/dd/yy):